Tag: ACN

TBIO Options Update & More

Translate Bio, Inc. TBIO – Update: 

We were just mentioning our successful MRNA calls from Monday morning in yesterday’s report. In that same report to kick off this week, we also formulated an extended-term options idea on TBIO. After some solid sessions have gone on the books this week, we’re swinging back around to check into our total possible gains.

We targeted the TBIO 08/20 $17.50-20 Calls, and on the strength of the stock running from 18.02-22.49 (+25%) over the span of the past three sessions, we have seen some pretty solid runs.

Here are the trading ranges and total possible gains that were made available by these TBIO Calls:  

TBIO 08/20 $17.50-20 Calls
$65: 2.88-5.20 (+81%)
$70: 1.65-4.00 (+142%)

Meanwhile, with plenty of time remaining until expiration and plenty of upside potential on the TBIO chart, we’ll continue to track these targets in the days and weeks ahead.

Fresh Options Ideas:
CCIV Weekly $25-26 Calls
DRI 07/16 $140-145 Calls
ACN Weekly $292.50-297.50 Calls
EXPI 07/16 $40 Calls

Extended Watchlist:
ZNOG, BSSP, ADSV, MRIN, ARAV, GTT, IGC, EVIO, PRPM

Finishing Up a Solid Trading Week

CURE Pharmaceutical Holding Corp. (OTCMKTS:CURR)

As we mentioned in Wednesday morning’s premarket report, CURE officials conducted a Zoom webcast on the current state of the company yesterday afternoon. Today we just wanted to remind our readers that if you were unable to catch the presentation live, you can still get it on demand at the following link: https://zoom.us/webinar/register/WN_BrUIQ-jlR0OkoNC8GNCnhg

CURE has a lot happening right now, so we would highly suggest getting the story straight from the horse’s mouth and hearing what company directors had to say.
_______

Direct all investor inquiries on CURR to:

Gary Zwetchkenbaum
Plum Tree Consulting LLC
Phone: (718) 224-3123
Cell: (516) 455-7662
Website: www.plumtreeconsultingllc.com


Options Recaps

Our LEN and ACN idfeas from yesterday’s report panned out pretty well, and we have a couple of fresh ideas to add to the mix as well.

LEN Weekly $75.50-77 Calls
$75.50: 2.55-6.14 (+140%)
$76: 2.26-5.60 (+148%)
$76.50: 1.51-5.10 (+238%)
$77: 1.35-4.90 (+263%)
_______

ACN Weekly $255-262.50 Calls
$255: 9.99-15.00 (+50%)
$257.50: 8.19-12.30 (+50%)
$260: 5.79-10.01 (+73%)
$262.50: 4.15-9.00 (+117%)
______

Fresh Options Ideas:
WGO Weekly $60 Calls
DRI Weekly $115 Calls

Extended Watchlist:
BSRC, CEOS, SAML, TEUM, BCII, CBGH

PBIO News, Options Ideas

Pressure BioSciences, Inc. (OTCMKTS:PBIO)

We are checking in with PBIO this morning, as the company released a PR pertaining to the adoption of its Pressure Cycling Technology (PCT) in coronavirus research, which you’ll find below. We are also still awaiting news of the company’s partnership with Cannaworx, and the launch of its FDA-registered immune booster this month, as indicated by PBIO on December 4th.

Since we began tracking this stock, we have witnessed an impressive trading range as PBIO has moved from a low of 1.80 to yesterday’s new high of 2.75. That works out to an upswing of 53% inside of two weeks, and gives us plenty of reason to be interested in what comes next.

SOUTH EASTON, Mass., Dec. 17, 2020 /PRNewswire/ — Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmetics, nutraceuticals, and food & beverage industries, today announced a remarkable convergence of global research teams announcing pivotal new insights into COVID-19 biology and disease processes. These data point to potential new pathways to next generation diagnostics and treatments. All teams selected PBI’s Pressure Cycling Technology (“PCT”) platform for their critical sample preparation steps, to help ensure that the greatest abundance and diversity of reproducible results would be revealed in the thousands of proteins involved in the affected biochemical pathways. (>>View Full PR via OTCMARKETS)
_____

We also have a video presentation on the PBIO chart that we would suggest our readers take a moment to view:


PBIO Video Chart 
_____

For All Investor Inquiries on PBIO,Contact:
Gary Zwetchkenbaum, Plum Tree Consulting LLC
Email: gzplumtree@gmail.com
Phone: (516) 455-7662
Web: plumtreeconsultingllc.com 

The Toro Co. TTC – Recap 

We included the TTC Weekly $90-95 Calls as a possible options trading idea in yesterday morning’s premarket report. With the help of a solid day for the markets as a whole, and the company reporting strong figures for both Q4 and the the 2020 Fiscal Year, we saw instant results.

Here are the total possible intraday gains that were on the table for those targets: 

TTC Weekly $90-95 Calls
$90: 1.15-2.61 (+127%)
$95: .05-.15 (+200%)

_____

Fresh Options Ideas:
JBL Weekly $43.50-45 Calls
LEN Weekly $75.50-77 Calls
ACN Weekly $255-262.50 Calls